Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.
Molecular Weight:
413.28
Purity:
95.52%
CAS Number:
[847499-27-8]
Formula:
C21H28BN3O5
Target:
Proteasome|||Apoptosis|||NF-kappaB
T6027
* VAT and and shipping costs not included. Errors and price changes excepted